DUBLIN–(BUSINESS WIRE)–The “Cataract Surgery Devices Market Research Report by Product (Femtosecond Laser Equipment, Intraocular Lens, and Ophthalmic Viscoelastic Device), End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa…
Author: Business Wire
Eye Care Products Markets in China: Demand to Grow at 8% Through 2031 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Eye Care Products Markets in China” report has been added to ResearchAndMarkets.com’s offering. China’s demand for Eye Care Products has grown at a fast pace in the past decade. In the next decade, both production and dema…
North America Anti-Blue Ray Myopia Lenses Market to Grow by 7% Yearly Through 2028 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “North America Anti-Blue Ray Myopia Lenses Market Size, Share & Industry Trends Analysis Report By Distribution Channel (Retail Stores, Hospital & Clinics, and E-Commerce), By Type (Single, Bifocal, Trifocal), By Co…
Zenni Launches “Fast Frame” to Ship Glasses in 24 Hours or Less
NOVATO, Calif.–(BUSINESS WIRE)– #Eyewear–Zenni, the online eyewear retail leader, today announced Fast Frame, a premium service to expedite new eyeglass orders in a fraction of standard delivery times. Fast Frame provides the option for Zenni’s U.S….
TearLab® Announces Corporate Name Change to Trukera™ Medical, Positions Company for Further Expansion in Corneal Health
SOUTHLAKE, Texas–(BUSINESS WIRE)–TearLab® Corporation, the global leader in ophthalmic point-of-care diagnostics, announced today that it will be expanding its position in corneal health under the new name Trukera™ Medical. The rebranding reflects th…
Visus Therapeutics to Present at the Baird 2022 Global Healthcare Conference
SEATTLE–(BUSINESS WIRE)– #conferences–Visus Therapeutics, Inc. (“Visus”), a clinical stage biopharmaceutical company focused on treating complex and multifactorial conditions from the front to the back of the eye, today announced that Ben Bergo, co-…
Azura Ophthalmics Secures Grant to Evaluate AZR-MD-001 for Improved Vision Quality Related to Contact Lens Discomfort
TEL AVIV, Israel & MELBOURNE, Australia–(BUSINESS WIRE)–Azura Ophthalmics secures funding from CUREator to advance AZR-MD-001 for improved vision quality tied to contact lens discomfort.
Iveric Bio to Present at Upcoming Investor Conferences
PARSIPPANY, N.J.–(BUSINESS WIRE)–Iveric Bio announced that the Company will participate in fireside chats at two investor conferences in September 2022.
The Coretec Group Provides an Update on its CSpace Technology Partnership with The University of Adelaide
ANN ARBOR, Mich.–(BUSINESS WIRE)–The Coretec Group provided an update on its CSpace technology partnership with The University of Adelaide.
Glaukos Announces Positive Topline Outcomes for Both Phase 3 Pivotal Trials of iDose TR, Achieving Primary Efficacy Endpoints and Demonstrating Favorable Tolerability and Safety Profiles
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced positi…
Aura Biosciences to Present Phase 2 Safety Data Evaluating Suprachoroidal Administration of Belzupacap Sarotalocan (AU-011) in Patients with Choroidal Melanoma at the ESMO 2022 Congress
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aura Biosciences Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced that Phase 2 data e…
Visit Seattle Partners with EnChroma to help Color Blind Guests Experience the Incredible Vibrancy of Seattle Museums & Cultural Institutions
SEATTLE–(BUSINESS WIRE)– #VisitSeattle–Visit Seattle Partners with EnChroma to help Color Blind Guests Experience the Incredible Vibrancy of Seattle Museums and Cultural Institutions
Warby Parker Announces Participation in the Goldman Sachs 29th Annual Global Retailing Conference
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) a direct-to-consumer lifestyle brand focused on vision for all, today announced that Co-Founders and Co-CEOs Neil Blumenthal and Dave Gilboa will be presenting at the Goldman Sachs 29th Annual G…
Kubota Vision Announces the Results of Clinical Study in Children Using Wearable Myopia Control Device based on Kubota Glass Technology
SEATTLE–(BUSINESS WIRE)–Kubota Vision Inc. (“Kubota Vision” or the “Company”), a clinical-stage specialty ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced today the results from a c…
EyeSouth Partners Affiliates With Raleigh Ophthalmology, Representing the Network’s 31st Affiliation and First Practice in North Carolina
ATLANTA–(BUSINESS WIRE)–EyeSouth Partners (“EyeSouth” or the “Company”) is pleased to announce that it has completed an affiliation with Raleigh Ophthalmology (“ROPC”). The affiliation represents EyeSouth’s thirty-first affiliation overall and first …
Global Dry Eye Clinical Trial Pipeline Market Research Report 2022 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Dry Eye Clinical Trial Pipeline Highlights – 2022” report has been added to ResearchAndMarkets.com’s offering. The report provides the most up-to-date information on key pipeline products within the global Dry Eye m…
Global Ophthalmology EMR Software Market to Reach $470.42 Million by 2027 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmology EMR Software Market Research Report by Type (Ambulatory EMR and Inpatient EMR), Product Type, End-user, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumula…
Ray Therapeutics Appoints Dr. Peter Francis as Chief Scientific & Medical Officer and Jenny Holt as SVP, Program Portfolio Management
SAN FRANCISCO–(BUSINESS WIRE)–Ray Therapeutics Appoints Dr. Peter Francis as Chief Scientific Officer and Jenny Holt as SVP, Program Portfolio Management
Glaukos Announces More Than 1 Million iStent® Technologies Implanted Worldwide
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced a sign…
Iveric Bio Announces Positive Topline Data from Zimura® GATHER2 Phase 3 Clinical Trial in Geographic Atrophy
PARSIPPANY, N.J.–(BUSINESS WIRE)–Iveric Bio announced positive topline results from GATHER2, the Company’s second Phase 3 clinical trial of Zimura, for the treatment of GA.